Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Zighelboim, I; Wright, JD; Gao, F; Case, AS; Massad, LS; Mutch, DG; Powell, MA; Thaker, PH; Eisenhauer, EL; Cohn, DE; Valea, FA; Secord, AA; Lippmann, LT; Rader, JS

Published Date

  • May 20, 2012

Published In

Volume / Issue

  • 30 / 15

Published By


  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • June 1, 2012

Conference End Date

  • June 6, 2012